Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT02979028
Other study ID # zxy
Secondary ID
Status Not yet recruiting
Phase N/A
First received November 29, 2016
Last updated April 15, 2017
Start date May 1, 2017
Est. completion date April 2018

Study information

Verified date November 2016
Source Second Hospital of Shanxi Medical University
Contact Xiao-ying Zhao
Phone 13513616985
Email zhaoxy06@163.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a single center, randomized, double-blinded, controlled clinical trial. The purpose of this study is to to determine whether treating by transcutaneous electrical acupoint stimulation (TEAS) during perioperative could alleviate the postoperative complications in patients undergoing artificial joint replacement surgery.


Description:

The complications from patients accepted artificial joint replacement surgery will directly or indirectly affect the prognosis of the patients, resulting in patients with delayed recovery and increase the hospitalization time and cost. Serious complications can lead to patients deaths during perioperative period. It has been proved that the electroacupuncture application during perioperative period can reduce the dosage of anesthetic drugs, and has a good effect on the protection of the heart and brain. At the same time, the electroacupuncture can also regulate the body's immune function, reduce allergy, reduce postoperative pain and so on.Compared with acupuncture, transcutaneous electric acupoint stimulation (TEAS) is a noninvasive technique that has similar effects to acupuncture. The investigators hypothesize that TEAS before anesthesia and during surgery would decrease the morbidity and mortality of postoperative complications in 30 days after artificial joint replacement surgery.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 300
Est. completion date April 2018
Est. primary completion date March 2018
Accepts healthy volunteers No
Gender All
Age group 60 Years to 89 Years
Eligibility Inclusion Criteria:

1. ASA?-?,elective operation patients

2. No other severe complications history

3. Able to give informed consent

Exclusion Criteria:

1. Having severe comorbidity resulting in estimated life expectancy <1 year.

2. Infection at the electroacupuncture site.

3. Suffered from neurologic disorder or impaired mental state

4. Participate in the other clinical trial 3 months before the enrollment

5. No suitable to participate in this experiment

Study Design


Related Conditions & MeSH terms


Intervention

Device:
TEAS
Transcutaneous electrical acupoint stimulation

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Second Hospital of Shanxi Medical University

References & Publications (7)

Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW, Ray JG. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004 Sep;126(3 Suppl):338S-400S. Review. — View Citation

Hou L, Chen C, Xu L, Yin P, Peng W. Electrical stimulation of acupoint combinations against deep venous thrombosis in elderly bedridden patients after major surgery. J Tradit Chin Med. 2013 Apr;33(2):187-93. — View Citation

Huddleston JI, Maloney WJ, Wang Y, Verzier N, Hunt DR, Herndon JH. Adverse events after total knee arthroplasty: a national Medicare study. J Arthroplasty. 2009 Sep;24(6 Suppl):95-100. doi: 10.1016/j.arth.2009.05.001. Epub 2009 Jul 4. — View Citation

Krecisz B, Kiec-Swierczynska M, Chomiczewska-Skóra D. Allergy to orthopedic metal implants - a prospective study. Int J Occup Med Environ Health. 2012 Sep;25(4):463-9. doi: 10.2478/S13382-012-0029-3. Epub 2012 Dec 3. — View Citation

Ni X, Xie Y, Wang Q, Zhong H, Chen M, Wang F, Xiong L. Cardioprotective effect of transcutaneous electric acupoint stimulation in the pediatric cardiac patients: a randomized controlled clinical trial. Paediatr Anaesth. 2012 Aug;22(8):805-11. doi: 10.1111/j.1460-9592.2012.03822.x. Epub 2012 Mar 2. — View Citation

Singh JA, Jensen MR, Harmsen WS, Gabriel SE, Lewallen DG. Cardiac and thromboembolic complications and mortality in patients undergoing total hip and total knee arthroplasty. Ann Rheum Dis. 2011 Dec;70(12):2082-8. doi: 10.1136/ard.2010.148726. Epub 2011 Oct 21. — View Citation

Yang L, Yang J, Wang Q, Chen M, Lu Z, Chen S, Xiong L. Cardioprotective effects of electroacupuncture pretreatment on patients undergoing heart valve replacement surgery: a randomized controlled trial. Ann Thorac Surg. 2010 Mar;89(3):781-6. doi: 10.1016/j.athoracsur.2009.12.003. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary The incidence of postoperative complications Participants will be followed for the incidence of postoperative complications within 30 days after operation
Secondary length of postoperative hospital stay Participants will be followed for the duration of hospital stay an expected average of 1 week
Secondary Quality of life during 30 days after surgery evaluate the quality of life after surgery by WHO QOL-BREF scale with interview ,WHO QOL-BREF scale includes five aspects: physical, psychological, social, environmental, integrated, divided into five levels One month
Secondary ICU transfer rate after operation Participants will be followed for ICU transfer rate after operation One month
See also
  Status Clinical Trial Phase
Completed NCT00767780 - The Effect of a New Biomechanical Device N/A
Completed NCT05248854 - Effects of Sensorimotor and Core Stabilization Exercises After Total Knee Arthroplasty N/A
Recruiting NCT03328611 - MCJR Joint Replacement Clinical Outcomes Database
Completed NCT04515758 - Determining the Feasibility of Implementing a Combined Cognitive and Exercise Training Program for Older Adults in a Community Setting. N/A